+499.5%
MRNA vs ALL
+28.3%
+471.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -3.1% |
| 7D | +5.5% | 0.0% | +5.5% | +5.5% |
| 30D | +158.7% | -1.5% | +160.2% | +157.7% |
| 3M | +182.1% | +23.6% | +158.5% | +211.5% |
| 6M | +151.8% | +22.3% | +129.5% | +177.2% |
| YTD | +393.6% | +26.5% | +367.0% | +456.2% |
| 1Y | +499.5% | +27.0% | +472.5% | +565.9% |
| All | +499.5% | +28.3% | +471.1% | +565.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ALL.
Daily Out/Under-Performance
Portfolio return minus ALL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling